Facebook Hiring Dozens for Secretive Division, Rumored to be Working on Brain-Scanning Technology and Other Med Device
Why Struggling Bristol-Myers Squibb (BMY) Could Take Out This Danish Biotech in Major €500M Deal
How This Drug Candidate Could be a Winner in Gilead (GILD)'s Pipeline
4 Small-Cap Biotechs to Consider if Gilead (GILD) Isn’t Doing it For You
Questions Arise Over This Bay Area Biotech CEO's Doctorate Degree and His Time at the University of Pennsylvania
Heat Biologics (HTBX) Rockets as Lung Cancer Med Hits Mid-Stage Goals
Ex-Novartis AG (NVS) Exec to Take the Reins at Bay Area's Forty Seven on May 1
Former Celgene (CELG) Exec to Helm Cipher Pharma (DND.TO)
Filings Reveal Alnylam (ALNY) CEO's Pay Dropped Almost 80% in 2016
For Sale: Nektar Therapeutics (NKTR) Plans to License Hot New Opioid Drug
Cerulean (CERU) to Slash More Than Half of Its Remaining Staff, Merge With SoCal Biotech
3 Beaten-Up Biotech Stocks: Are They Bargains?
Esperion (ESPR) Hits A New High After Positive Feedback For Its Heart Drug From The FDA
Anti-PCSK9 Drugs: An Ingenious Solution For A Problem That's Mostly Already Solved
Ex-GlaxoSmithKline (GSK) Scientists' Pulmocide Hauls in $30.4 Million
Investors Squeal With Delight as Eli Lilly (LLY)'s Breast Cancer Combo Succeeds in Phase III, Faces Tough Competition from Pfizer (PFE) and Novartis AG (NVS)
Trump Budget Would Double FDA Product Review Fees, Leading to Faster Drug Approvals
Is There A Link Between Climate Change And Diabetes? Leiden University Medical Center Study Reveals
See All News >
//-->